-+ 0.00%
-+ 0.00%
-+ 0.00%

Oculis Plans R&D Day to Highlight Late-Stage Drug Pipeline

PUBT·11/09/2026 07:02:11
Listen to the news
Oculis Plans R&D Day to Highlight Late-Stage Drug Pipeline
  • Oculis will host an in-person and virtual R&D Day on December 8, 2026, at St. Regis New York, starting at 10 a.m. EST.
  • Presentations will cover licaminlimab's registrational trial in dry eye disease and Privosegtor's development for optic neuritis and acute multiple sclerosis relapses.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oculis Holding AG published the original content used to generate this news brief on November 09, 2026, and is solely responsible for the information contained therein.